




Searching News Database: Biodel
HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
HSMN NewsFeed - 29 Nov 2016
Albireo Expands Team, Appoints Martha J. Carter as Chief Regulatory Officer
Albireo Expands Team, Appoints Martha J. Carter as Chief Regulatory Officer
HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
HSMN NewsFeed - 15 Jul 2013
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
HSMN NewsFeed - 30 Dec 2009
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
HSMN NewsFeed - 20 May 2008
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
Additional items found! 20

Members Archive contains
20 additional stories matching:
Biodel
(Password required)
Biodel
(Password required)